|
2019
|
Invention
|
Cholestyramine formulations and methods of use. The present disclosure relates to cholestyramine ... |
|
2018
|
Invention
|
Pharmaceutical composition of entecavir and process of manufacturing.
The present invention rela... |
|
2017
|
Invention
|
Abuse deterrent pharmaceutical composition.
A modified release orally administrable abuse-deterr... |
|
|
Invention
|
Spirocyclic containing compounds and pharmaceutical uses thereof.
The present inv... |
|
|
Invention
|
A smac mimetic compound for use in the treatment of proliferative diseases. The present invention... |
|
2016
|
Invention
|
Nystatin nanosuspension formulation using high pressure homogenisation.
The present in... |
|
|
Invention
|
New benzimidazoles derivatives as tec kinases family inhibitors. The present invention relates to... |
|
|
Invention
|
Heterocyclic tec-family kinase inhibitors. Compounds having the Formula (I), and enantiomers, dia... |
|
|
Invention
|
Spirocyclic containing compounds and pharmaceutical uses thereof.
The present inventio... |
|
|
Invention
|
Inhibitors of the tec kinase enzyme family. The present invention relates to a novel family of ki... |
|
|
Invention
|
A smac mimetic compound for use in the treatment of proliferative diseases.
The presen... |
|
2015
|
Invention
|
Orally disintegrating tablet of nabilone comprising mannitol-based granules.
Orally disintegrati... |
|
|
Invention
|
Orally disintegrating tablet of nabilone comprising mannitol-based granules. Orally disintegratin... |
|
2014
|
Invention
|
Protein kinase inhibitors.
The present invention relates to a novel family of protein kinase inh... |
|
|
Invention
|
Protein kinase inhibitors. The present invention relates to a novel family of protein kinase inhi... |
|
|
Invention
|
Abuse deterrent immediate release formulation.
The present invention relates to an immediate rel... |
|
|
Invention
|
Abuse deterrent immediate release formulation. The present invention relates to an immediate rele... |
|
|
Invention
|
Iap bir domain binding compounds. A compound of Formula I
or a salt thereof, methods for the pr... |
|
|
Invention
|
Orally disintegrating tablet of nabilone and method of manufacturing.
The present... |
|
2013
|
Invention
|
Protein kinase inhibitors.
The present invention relates to a novel family of protein ... |
|
|
Invention
|
Abuse deterrent pharmaceutical composition comprising konjac glucomannan. A modified release oral... |
|
|
Invention
|
Protein kinase inhibitors. The present invention relates to a novel family of inhibitors of prote... |
|
|
Invention
|
Abuse deterrent immediate release formulation.
The present invention relates to an imm... |
|
|
Invention
|
Pharmaceutical composition of entecavir and process of manufacturing. The present invention relat... |
|
|
Invention
|
Protein kinase inhibitors.
The present invention relates to a novel family of inhibito... |
|
2012
|
Invention
|
Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufactur... |
|
|
Invention
|
Pharmaceutical composition of amphetamine mixed salts. Orally administrable modified release phar... |
|
|
Invention
|
Abuse deterrent pharmaceutical formulation.
A modified release orally administrable ab... |
|
|
Invention
|
Protein kinase inhibitors.
The present invention relates to a novel family of inh... |
|
|
Invention
|
Pharmaceutical composition of entecavir and process of manufacturing.
The present inve... |
|
2011
|
Invention
|
Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufac... |
|
|
Invention
|
Protein kinase inhibitors and uses thereof.
The present invention relates to a new cla... |
|
|
Invention
|
Controlled release formulations of tolterodine and process of manufacturing.
The prese... |
|
1997
|
G/S
|
Pharmaceutical preparations for the treatment of heartburn. |
|
|
G/S
|
Nutritional supplements, namely phenolic compounds, vitamins, or minerals. |
|
1994
|
G/S
|
Pharmaceutical packaging unit used to dispense unit-dose quantities of solutions for nebulization. |
|
1983
|
G/S
|
Sodium fluoride dental preparation. |
|
1965
|
G/S
|
Medicinal preparation for use as an analgesic. |
|
1954
|
G/S
|
Antiseptic preparation for surgical and hygienic use. |
|
1953
|
G/S
|
Pharmaceutical preparations consisting of combinations of analgesic and antipyretic. |
|
1952
|
G/S
|
Pharmaceutical preparations in the form of tablets consisting of a plurality of analgesic medicam... |
|
1937
|
G/S
|
Products of secondary amyl barbituric acid and the sodium salts thereof, useful as hypnotics. |
